ERISA Ledger · U.S. DOL EBSA Form 5500 (2023)

Rubius Therapeutics, INC.

Official 2023 U.S. DOL Form 5500 summary for Rubius Therapeutics, INC. (Rubius Therapeutics 401(k) Plan · EIN 46-2688109 · PN 001): $42,400 net assets, 64 active participants, and $24.19 per $10,000 (24.19 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorRubius Therapeutics, INC.
Filing IdentifierRubius Therapeutics 401(k) Plan · EIN 46-2688109 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2023)$42,400
Active Participants64
Direct Admin Fee Rate$24.19 per $10,000 (24.19 bps)
Cohort Peer Median$34.74 per $10,000 (34.74 bps)
Primary Recordkeeper / ProviderADP Retirement Services
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI